AstraZeneca PLC is 74.6x more valuable than CATALYST PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $3.84 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | CPRX | AZN |
|---|---|---|
| Market cap | $3.84 B | $286.27 B |
| US-listed rank | #1606 | #45 |
| Revenue (latest FY) | $588.99M | - |
| Net income (latest FY) | $214.33M | - |
| Net margin | 36.4% | - |
| P/E (trailing FY) | 17.9 | - |
| SEC filings | 1,337 | 1,004 |
AstraZeneca PLC is 74.6x more valuable than CATALYST PHARMACEUTICALS, INC. by market capitalization ($286.27 B vs $3.84 B).
Full pages: CATALYST PHARMACEUTICALS, INC. and AstraZeneca PLC, or browse the full rankings.